The recent development, application, and future prospects of muscle atrophy animal models DOI Creative Commons
Gongchang Zhang,

Fengjuan Hu,

Tingting Huang

et al.

MedComm – Future Medicine, Journal Year: 2024, Volume and Issue: 3(4)

Published: Dec. 1, 2024

Abstract Muscle atrophy, characterized by the loss of muscle mass and function, is a hallmark sarcopenia cachexia, frequently associated with aging, malignant tumors, chronic heart failure, malnutrition. Moreover, it poses significant challenges to human health, leading increased frailty, reduced quality life, heightened mortality risks. Despite extensive research on consensus in their assessment remains elusive, inconsistent conclusions regarding molecular mechanisms. atrophy models are crucial tools for advancing this field. Currently, animal used clinical basic scientific studies induced through various methods, including genetic editing, nutritional modification, exercise, wasting diseases, drug administration. also include vitro small organism models. value, each these has certain limitations. This review focuses limitations diverse applications understand encourage rational use future research, therefore deepening understanding underlying pathophysiological mechanisms, ultimately exploration therapeutic strategies cachexia.

Language: Английский

Appendicular lean mass in women with rheumatoid arthritis: Focus on immunological markers DOI Creative Commons
O. V. Dobrovolskaya, Н. В. Демин, А. Yu. Feklistov

et al.

Rheumatology Science and Practice, Journal Year: 2024, Volume and Issue: 62(5), P. 529 - 534

Published: Nov. 1, 2024

Aim – to evaluate the association among appendicular lean mass and immunological markers of blood serum in women with rheumatoid arthritis (RA). Material methods . 200 RA (median age 60.0 [52.5; 65.5] years) were enrolled study. Using dual-energy X-ray absorptiometry (ALM) was measured determine sarcopenic phenotype body composition. The assessment C-reactive protein (CRP), factor, antibodies cyclic citrullinated peptide also performed. levels myostatin, follistatin, interleukin 6 (IL-6), IL-6 receptors, insulin-like growth factor 1 (IGF-1), adiponectin, leptin, fibroblast 23 (FGF23), tumor necrosis SF12 (superfamily member 12) studied 87 patients. Results According presence patients differed CRP (8.6 [1.3; 22.2] 5.6 [1.2; 17.4] mg/l, respectively; p=0.041) leptin (3.8 [2.4; 5.7] 5.4 [3.8; 6.9] ng/ml, p=0.030). ALM correlated CRP, follistatin leptin. Linear multivariate regression analysis revealed between index (β=–0.35; p=0.007), IGF1 (β=–0.38; p=0.002), (β=0.36; p=0.004) FGF23 (β=0.33; p=0.008). Conclusion study showed that there is an level IGF-1, RA.

Language: Английский

Citations

0

The recent development, application, and future prospects of muscle atrophy animal models DOI Creative Commons
Gongchang Zhang,

Fengjuan Hu,

Tingting Huang

et al.

MedComm – Future Medicine, Journal Year: 2024, Volume and Issue: 3(4)

Published: Dec. 1, 2024

Abstract Muscle atrophy, characterized by the loss of muscle mass and function, is a hallmark sarcopenia cachexia, frequently associated with aging, malignant tumors, chronic heart failure, malnutrition. Moreover, it poses significant challenges to human health, leading increased frailty, reduced quality life, heightened mortality risks. Despite extensive research on consensus in their assessment remains elusive, inconsistent conclusions regarding molecular mechanisms. atrophy models are crucial tools for advancing this field. Currently, animal used clinical basic scientific studies induced through various methods, including genetic editing, nutritional modification, exercise, wasting diseases, drug administration. also include vitro small organism models. value, each these has certain limitations. This review focuses limitations diverse applications understand encourage rational use future research, therefore deepening understanding underlying pathophysiological mechanisms, ultimately exploration therapeutic strategies cachexia.

Language: Английский

Citations

0